Novitor Insights
Trend intelligence covering consumer healthcare and life sciences.
Novitor Insights tracks emerging developments across the consumer health landscape - from clinical trials and capital markets to product launches and consumer signals. Written for investors, founders, and operators who need to know what is moving before it reaches the mainstream.
Intelligence
The view from the frontier
Novitor monitors developments across the consumer healthcare and life sciences landscape - tracking companies, capital flows, scientific activity, and consumer behaviour - and distils them into structured briefings.
Data
Uncovering data
Published three times per week, Novitor Insights covers developments as they emerge - not after they have been reported, analysed, and priced in by the market.
Analysis
Discovering opportunity
Written for investors, founders, and operators in consumer healthcare and life sciences who require data-grounded intelligence, not editorial opinion.
Novitor Insights
Selected topics
Capital Markets
Where the money is moving
Venture rounds, M&A activity, and public market signals across consumer health and life sciences. We track who is funding what and what it signals about where the category is heading.
Digital Health
Technology reshaping care delivery
From remote monitoring to AI-assisted diagnostics, digital health is restructuring how consumers access and experience healthcare. We cover the companies, products, and data driving that shift.
Clinical Research
Trial results that move markets
Phase II and III readouts with direct relevance to consumer health categories. We translate the science into commercial implications without the PhD.
Consumer Behaviour
How health consumers are changing
Spending patterns, category adoption, and behavioural shifts across nutrition, fitness, longevity, and self-care. The consumer data that precedes the market data.
Longevity
The science and business of living longer
Biological age, metabolic health, and the emerging commercial infrastructure around lifespan extension. One of the fastest-moving categories in consumer life sciences.
Regulatory
Policy decisions with commercial consequences
FDA decisions, EMA guidance, and regulatory developments that reshape what can be sold, claimed, and prescribed. We track the rulings before they reach the headlines.
Nutrition & Metabolic Health
Beyond diet, the metabolic revolution
GLP-1 therapeutics, continuous glucose monitoring, and the convergence of nutrition science with clinical medicine. The category is expanding faster than most analysts have modelled.
Mental Health
A category in structural expansion
Digital therapeutics, psychedelic-assisted treatment, and the mainstreaming of mental health as a consumer category. Capital and science are moving in parallel.
Women's Health
A historically underserved market finding its moment
Femtech, reproductive health, and menopause care are attracting serious capital and clinical attention. We cover the companies and research driving the category forward.
Science & Product
From bench to shelf
New ingredients, formulations, and delivery mechanisms moving from research into commercial products. The pipeline intelligence that informs category strategy.
In Depth
Coming Soon
Video overview
Pricing
Free
€0
Per month
- 3–4 insights per issue
- Published three times per week
- Access to free archive
Paid
€19.99
Per month · or €199/year
- Full access — all insights
- Deep dive analysis
- Analytics dashboard
- Monthly reports
- Full archive access
Coming soon
Platform
Included
With every Platform subscription
- Full Insights access included
- Company and market intelligence
- Social intelligence
- Science and product intelligence
- Early access — waitlist open
Looking for custom intelligence?
Novitor works directly with investment firms, operators, and research organisations that require intelligence beyond the standard publication - bespoke datasets, custom coverage scope, and dedicated analytical outputs.